Clinical isolates of Acinetobacter baumannii (n = 470) were collected during a 7-year period and investigated for the genetic determinants of resistance to expanded-spectrum beta-lactams. Thirty-one isolates produced the TEM-92 extended-spectrum beta-lactamase (ESBL) and were clonally related. This is the first report of A. baumannii producing a TEM-type ESBL.
Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum beta-lactamase.
LUZZARO, FRANCESCO;TONIOLO, ANTONIO
2007-01-01
Abstract
Clinical isolates of Acinetobacter baumannii (n = 470) were collected during a 7-year period and investigated for the genetic determinants of resistance to expanded-spectrum beta-lactams. Thirty-one isolates produced the TEM-92 extended-spectrum beta-lactamase (ESBL) and were clonally related. This is the first report of A. baumannii producing a TEM-type ESBL.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ANTIMICROBIAL_AGENTS_CHEMOTHERAPY_2007.pdf
accesso aperto
Descrizione: PDF editoriale
Tipologia:
Altro materiale allegato
Licenza:
Creative commons
Dimensione
201.59 kB
Formato
Adobe PDF
|
201.59 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
